Abstract :
The approach of the unique liver disease in pregnancy has not changed much. For most of the liver
nd rd diseases that manifest during the 2 and 3 trimester, the important concept is to consider delivery promptly or at the appropriate time by consideration of maternal health and newborn maturity, and providing continuous intensive monitoring before delivery and at postpartum period. Because the clinical management of the patients with unique liver diseases in pregnancy is alike, liver biopsy is not always indicated, especially if preeclampsia, eclampsia, HELLP syndrome and AFLP are the differential diagnosis. Nowadays, genetic testing and counseling for inherited genetic diseases in newborns and the women becomes more crucial. The risk of disease recurrence in subsequent pregnancy needs to be acknowledged to the women and their family.
[Thai J Gastroenterol 2005; 6(2): 94-99] |
file/Thai-Journal-of-gastroenterology-vol-6-no-2-3762286.pdf